Non-high-density lipoprotein cholesterol
Biomarker2 papers1 finding
- Humans1
Interventions
1Enlicitide
downin humans1High certainty
1 study
Enlicitide
downin humans1High certainty
Enlicitide decreases non-high-density lipoprotein cholesterol in humans (MD: -49.42 pp (95% CI: -54.23 to -44.60)).
Reviewhypercholesterolemia or heterozygous familial hypercholesterolemia
Enlicitide, a Novel Oral Macrocyclic Peptide PCSK9 Inhibitor for Lipid Lowering: A Systematic Review and Meta-Analysis · Journal of cardiovascular development and disease · 20 Aug 2026
Latest
20Workplace noise linked to heart risk markers in Chinese workers
In 765 Chinese workers, a cross-sectional study linked greater cumulative noise exposure to higher blood fat risk measures and shorter protective caps…In 765 Chinese workers, a cross-sectional study linked greater cumulative noise exposure to higher blood fat risk measures and shorter protective caps on chromosomes.
Development of a lipid-glycaemic prediction model for gestational diabetes mellitus: a single-Centre retrospective study
Cumulative non-HDL cholesterol is linked to CVD risk
Each 100-unit increase in cumulative exposure was associated with an adjusted hazard ratio of 1.07 for cardiovascular disease over nine years, driven…Each 100-unit increase in cumulative exposure was associated with an adjusted hazard ratio of 1.07 for cardiovascular disease over nine years, driven by earlier stages.